Rosty Raykov - 31 Mar 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Rostislav Raykov
Issuer symbol
FENC
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Apr 2023, 16:23:19 UTC
Previous filing
30 Dec 2022
Next filing
03 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option Award $0 +175,000 +12% $0.000000 1,583,333 31 Mar 2023 Common shares 175,000 $8.32 Direct F1, F2
transaction FENC Restricted Share Unit Award $0 +87,500 +5.5% $0.000000 1,670,833 31 Mar 2023 Common shares 87,500 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 31, 2023, Rostislav Raykov was granted incentive stock options to purchase 175,000 shares of the issuers common shares pursuant to the issuer's 2020 Equity Incentive Plan.
F2 1/3 of the shares subject to this option shall vest immediately and may be exercised as of March 31, 2024 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2026 and thereafter, 100% of the total number of shares subject to this option shall be vested.
F3 On March 31, 2023, Rostislav Raykov was awarded restricted share units to receive 87,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F4 1/3 of the shares subject to this award shall be released from restriction as of March 31, 2024 (the "Vesting Commencement Date"). 1/24 of the award shall be released from restriction as of the last day of each month following the Vesting Commencement Date. As of March 31, 2026 and thereafter, 100% of the total number of shares subject to this award shall be released.